In addition to inhibiting Drp1 activity, mdivi-1 exerts antioxidative, antiapoptotic, and anti-inflammatory effects (Deng et al., 2020; Bordt et al., 2022; Liu et al., 2022), and thus it can prevent AKI development. The gene discussed is DNM1L; the disease is acute kidney injury.